| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8624606 | Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) | 2018 | 30 Pages |
Abstract
Adults in middle to late adulthood receiving EPA+DHA therapy demonstrated significantly greater reductions in circulating levels of proinflammatory cytokines compared with those receiving placebo therapy. EPA+DHA therapy may be an effective low-risk dietary intervention for assuaging the harmful effects of inflammaging.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Alai Tan, Brent Sullenbarger, Ruchika Prakash, Jodi C. McDaniel,